NEW YORK (GenomeWeb News) – Danish genomics and molecular diagnostics company Exiqon said today that revenues in the first quarter rose 33 percent year over year on the strength of its research products.

For the three months ended March 31, the company took in DKK31.8 million ($5.6 million) in revenues, up from DKK24.0 million a year ago. Research product sales and services, excluding original equipment manufacturing revenues, increased 34 percent to DKK25.7 million, with business in Europe and the rest of the world driving revenue growth, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.